Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Neoplasms × enzalutamide × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 74 Breast Neoplasms 9 Metastatic Castration Resistant Prostate Cancer 8 Neoplasms 7 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Prostate Cancer Metastatic 4 Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Non-metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer 2 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Seizures 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Prostate Carcinoma Metastatic to the Bone 1 Primary Dysautonomias 1 Primary Breast Cancer ER+ve 1 Pharmacokinetics of MDV3100 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Metastatic Progressive Castration-resistant Prostate Cancer 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Kidney Diseases 1

Interventions

Carboplatin 160 Paclitaxel 153 Bevacizumab 65 Topotecan 49 liposomal doxorubicin 47 Gemcitabine 47 Cisplatin 40 Cyclophosphamide 35 Docetaxel 34 Filgrastim 27 pembrolizumab 26 Doxorubicin 26 olaparib 25 niraparib 19 Drug Therapy 19 Taxes 18 Peripheral Blood Stem Cell Transplantation 18 Etoposide 15 Nivolumab 14 veliparib 13 sargramostim 12 Surveys and Questionnaires 12 Trabectedin 11 Immunoglobulin G 11 Ifosfamide 11 Disulfides 11 Albumin-Bound Paclitaxel 11 pazopanib 10 durvalumab 10 atezolizumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03464201 2023-02-22

GREKO III

Grupo Español de Tumores Huérfanos e Infrecuentes

Phase 2 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡